Answer
The selected tablet is licensed for acute lymphoblastic and acute promyelocytic leukaemia. Specialists also use it without a licence for conditions such as inflammatory bowel disease and autoimmune hepatitis.
Sources for this answer
- Mercaptopurine 50 mg tablets — Current selected SmPCemc · Summary of Product Characteristics
- NHSNHS · NHS medicine guidance
- NHS